Participate in Research

AWAKEN single dose Romidepsin Infusion in HIV-infected Adults

RESEARCH STUDY A5315: This study is designed to look at a one-time infusion of RMD to make sure it is safe, easy to take, and to see if it can wake up the hidden or sleeping HIV virus.  READ MORE

InMIND HIV-associated impairment in cognitive function

RESEARCH STUDY A5324: this study is to evaluate if the addition of Maraviroc (MVC) and Dolutegravir (DTG) (which are two antiretroviral [ARV] medications) to participants' existing ART regimens will improve participants' neurocognitive performance. READ MORE

Interferon-Free Therapy for Chronic Hepatitis C Virus

RESEARCH STUDY A5329: this study is to evaluate the safety, tolerability, and effectiveness of interferon-free HCV treatment in HIV/HCV coinfected adults who are taking antiretroviral (ARV) therapy. READ MORE

PLUS (DTG+3TC) treatment naïve dual anti-HIV medications

RESEARCH STUDY A5353: this study evaluates the combination of two anti-HIV medicines, dolutegravir (DTG, Tivicay) and lamivudine (3TC, Epivir) taken once a day, will provide a safe, effective, and well-tolerated treatment for HIV. DTG is a type of HIV medicine called an integrase inhibitor; READ MORE

The good news is, A CURE IS NEAR.   With you, we’re that much closer.
RESEARCH STUDY A5337: SAFETY AND EFFICACY OF SIROLIMUS FOR HIV RESERVOIR REDUCTION IN INDIVIDUALS ON SUPPRESSIVE ANTIRETROVIAL THERAPY  READ MORE


 

 

Emory-CDC HIV/AIDS Clinical Trials Unit

Get ready, exciting HIV prevention research coming your way.  READ MORE

Emory-Study of PrEP and Sexual Lubricant

We are conductiong a study of the effects of Pre-exposure orophylaxis (PrEP) and sexual lubricant use on the rectal mucosa.  READ MORE


CONTACT US

General Information: (404) 870-7700
STI Testing: (404) 870-7722
Volunteer: (404) 870-7764
Comment Line: (678) 999-1212
(Anonymous)